Briquilimab [CAS 2574591-89-0]
Partner: MedChemexpress LLC
| CAS No: | 2574591-89-0 |
| Applications: | COVID-19-immunoregulation |
| MW: | N/A |
| Formula: | N/A |
| SMILES: | [Briquilimab] |
| Purity: | 96.57 |
| Description: | Briquilimab (JSP-191) is a non-toxic humanized monoclonal antibody targeting CD117 (c-Kit) to deplete hematopoietic stem cell (HSC). Briquilimab has safety to clear host marrow niche space to enable sufficient donor HSC engraftment and immune reconstitution as primary method of severe combined immunodeficiency (SCID)[1]. |
| Shipping Conditions: | Ship on dry ice |
| Usage: | Research Use Only |
Insight Biotechnology Ltd reserves the right to change pricing without notice
